Stock Report

All about this stock under one free report Last Updated: 21-Sep-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Tenaya Therapeutics Inc (TNYA) Key Ratios

Stock Card factsheet share-fund-plan-icon

$0.68

up-down-arrow $0.01 (1.06%)

As on 18-Sep-2026 16:27EDT

Market cap

info icon

$152 Mln

Revenue (TTM)

info icon

$1 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

2.2

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue 393.33 -- -- -- --
EBIT -125.16 -86.37 -3.51 6.33 -163.21
Net Profit -125.16 -86.37 -3.51 6.33 -164.05
EPS -124.45 -39.45 43.35 20.66 10.79
Book Value -- -- -25.02 -43.23 -30.93
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMDec-25Dec-24
EBIT-Margin info -----7,723.97----
Net Margin info ---44,132.89-7,723.97----
Return on equity info -81.45-65.01-107.04-83.84-95.69
Return on Capital info -73.95-59.74---75.32-86.04
Return on Assets info -66.54-54.23-83.37-67.90-76.52
Debt to Equity (x) info ----0.000.090.15

Profitability

View Detailed Peer Comparison

ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Tenaya Therapeutics Inc (TNYA)
--
-75.32
-86.04
-60.48
-44.75
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

-107.04

Lower than Peers by 66.60

Profit after tax / Average Net worth * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Tenaya Therapeutics Inc (TNYA)
-107.04
-83.84
-95.69
-64.83
-47.39
Peer Median
-40.43
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

-83.37

Lower than Peers by 51.91

Profit after tax / Average Total assets * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Tenaya Therapeutics Inc (TNYA)
-83.37
-67.90
-76.52
-55.21
-41.53
Peer Median
-31.46
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

-7,723.97

Lower than Peers by 7,645.67

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Tenaya Therapeutics Inc (TNYA)
-7,723.97
--
--
--
--
Peer Median
-78.30
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

-7,723.97

Lower than Peers by 7,635.05

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Tenaya Therapeutics Inc (TNYA)
-7,723.97
--
--
--
-6,322.24
Peer Median
-88.92
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Profit Margin

0.00

Lower than Peers by 0.00

(Net profit + Depreciation) / Gross Sales * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Tenaya Therapeutics Inc (TNYA)
0.00
--
--
--
--
Peer Median
0.00
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Growth

View Detailed Peer Comparison

EBIT Growth

-3.51

Lower than Peers by 2.87

Year on year growth in operating profit (EBIT)

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Tenaya Therapeutics Inc (TNYA)
-3.51
18.48
10.44
1.22
-72.54
Peer Median
-0.64
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

-3.51

Higher than Peers by 3.57

Year on year growth in profit after tax

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Tenaya Therapeutics Inc (TNYA)
-3.51
18.48
10.44
-0.34
-77.54
Peer Median
-7.08
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

43.35

Higher than Peers by 28.70

Year on year growth in earnings per share

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Tenaya Therapeutics Inc (TNYA)
43.35
0.54
0.29
0.19
-0.33
Peer Median
14.65
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Book Value Growth

-47.98

Lower than Peers by 38.68

Year on year growth in book value per share

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Tenaya Therapeutics Inc (TNYA)
-47.98
--
--
--
--
Peer Median
-9.30
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Solvency

View Detailed Peer Comparison

Debt to Equity

--

--

Total debt / Net worth

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Tenaya Therapeutics Inc (TNYA)
--
0.09
0.15
0.09
0.06
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Short term debt to equity ratio

0.04

--

(Short term borrowings / Net worth)

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Tenaya Therapeutics Inc (TNYA)
0.04
0.02
0.03
0.03
0.02
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

4.52

Lower than Peers by 1.27

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Tenaya Therapeutics Inc (TNYA)
4.52
6.84
4.22
4.91
7.99
Peer Median
5.79
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

4.52

Lower than Peers by 1.14

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Tenaya Therapeutics Inc (TNYA)
4.52
--
--
--
8.81
Peer Median
5.66
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

--

--

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Tenaya Therapeutics Inc (TNYA)
--
--
--
--
-64,223.42
Peer Median
-2.09
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

27.79

Higher than Peers by 8.75

Debtors outstanding / Net Sales * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Tenaya Therapeutics Inc (TNYA)
27.79
--
--
--
--
Peer Median
19.04
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

0.01

Lower than Peers by 0.05

Sales / Average Total Assets

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Tenaya Therapeutics Inc (TNYA)
0.01
--
--
--
--
Peer Median
0.06
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Tenaya Therapeutics Inc (TNYA)
--
--
--
-838.73
-836.22
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Tenaya Therapeutics Inc (TNYA)
--
189.27
232.75
319.71
425.47
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Valuation

View Detailed Peer Comparison

Price / Earnings

--

--

Current share price divided by earning per share in the last twelve months

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Tenaya Therapeutics Inc (TNYA)
--
-1.20
-1.11
-1.78
-0.90
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Book Value

2.16

Lower than Peers by 2.56

Current share price divided by book value per share in the latest financial year

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Tenaya Therapeutics Inc (TNYA)
2.16
0.88
1.33
1.59
0.46
Peer Median
4.72
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Dividend Yield

--

--

Dividend per share in the past twelve months divided by current share price

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Tenaya Therapeutics Inc (TNYA)
--
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EV/EBITDA

-0.67

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Tenaya Therapeutics Inc (TNYA)
-0.67
-0.23
-0.74
-1.12
0.51
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Market Cap

152

Higher than Peers by 9

Current Share price multiplied by latest total number of shares outstanding

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Tenaya Therapeutics Inc (TNYA)
152
--
--
--
--
Peer Median
143
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...